-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$20.001069.59% Upside
Century Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Century Therapeutics, Inc.?
Century Therapeutics, Inc. has been rated by research analysts at Piper Sandler, Chardan Capital, H.C. Wainwright, Leerink Partners in the past 90 days.